(NASDAQ: LITS) Lite Strategy's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 106.3%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,267.99%.
Lite Strategy's earnings in 2026 is -$60,820,000.On average, 4 Wall Street analysts forecast LITS's earnings for 2026 to be -$128,758,162, with the lowest LITS earnings forecast at -$123,708,822, and the highest LITS earnings forecast at -$132,545,167.
In 2027, LITS is forecast to generate -$54,140,898 in earnings, with the lowest earnings forecast at -$52,017,726 and the highest earnings forecast at -$55,733,278.